Cortalix B.V.
PrivateLast Round
Seed
Mar 3, 2025
Total Funding Raised
$1.09M
Company Overview
Cortalix B.V. is a biotechnology company that specializes in the discovery and engineering of single-domain antibodies (VHH or nanobodies) for applications in molecular imaging, targeted therapy, and immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cortalix B.V. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Cortalix B.V. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 3, 2025 |
Cortalix B.V. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovatie Fonds Rabobank | Seed |
| Future Tech Ventures | Seed |
Cortalix B.V. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cortalix B.V.'s valuation, stock price, and market status.